PMID- 9924843
OWN - NLM
STAT- MEDLINE
DCOM- 19990329
LR  - 20131121
IS  - 0279-1072 (Print)
IS  - 0279-1072 (Linking)
VI  - 30
IP  - 4
DP  - 1998 Oct-Dec
TI  - A method of conducting therapeutic sessions with MDMA.
PG  - 371-9
AB  - A method for preparing clients and conducting therapeutic sessions with 
      3,4-methylenedioxymethamphetamine (MDMA) is described, with emphasis on the need 
      for careful attention to the mental set of therapists and clients and the setting 
      of the session. The therapists' belief was that MDMA inhibited the fear response 
      to a perceived emotional threat, allowing the client to place the emotional 
      sequelae of past experiences into a more realistic perspective in their current 
      emotional lives and relationships. Clients were carefully screened and prepared 
      until they had a clear purpose for the session, including a willingness to 
      experience and to learn from anything that might happen. Sympathomimetic effects 
      of MDMA determined the medical contraindications, and clients with histories of 
      serious functional psychiatric impairments were excluded. Total doses of 75-150 
      mg, plus 50 mg if requested later, were administered, followed by clients lying 
      down and listening to music with eyeshades and headphones during the peak MDMA 
      effect. Screening and follow-up questionnaires were utilized. Two case histories 
      are presented: a man achieving relief of pain from multiple myeloma, and a woman 
      finding relief from problems as the daughter of Holocaust survivors. Use of 
      consciousness-altering drugs in other contexts is discussed.
FAU - Greer, G R
AU  - Greer GR
AD  - Heffter Research Institute, Santa Fe, New Mexico, USA.
FAU - Tolbert, R
AU  - Tolbert R
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - J Psychoactive Drugs
JT  - Journal of psychoactive drugs
JID - 8113536
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Bone Neoplasms/complications
MH  - Depressive Disorder/drug therapy/psychology
MH  - Female
MH  - Hallucinogens/*therapeutic use
MH  - Humans
MH  - Male
MH  - Multiple Myeloma/complications
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*therapeutic use
MH  - Pain, Intractable/psychology/therapy
MH  - Psychotherapy/*methods
EDAT- 1999/01/30 00:00
MHDA- 1999/01/30 00:01
CRDT- 1999/01/30 00:00
PHST- 1999/01/30 00:00 [pubmed]
PHST- 1999/01/30 00:01 [medline]
PHST- 1999/01/30 00:00 [entrez]
AID - 10.1080/02791072.1998.10399713 [doi]
PST - ppublish
SO  - J Psychoactive Drugs. 1998 Oct-Dec;30(4):371-9. doi: 
      10.1080/02791072.1998.10399713.